Immediate Impact
65 standout
Citing Papers
Pancreatic cancer
2025 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Aaron Prendergast being referenced
STAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer
2019
AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial.
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Aaron Prendergast | 170 | 161 | 147 | 21 | 340 | |
| Vanessa Henriques | 104 | 107 | 190 | 18 | 362 | |
| Shinya Ohara | 147 | 156 | 131 | 28 | 362 | |
| Uğur Mungan | 138 | 63 | 146 | 27 | 327 | |
| Neil Fenn | 76 | 90 | 101 | 19 | 303 | |
| Yuancheng Gou | 103 | 138 | 167 | 16 | 384 | |
| Moritz Maas | 96 | 138 | 135 | 27 | 323 | |
| Yoshihisa Kawai | 105 | 89 | 88 | 23 | 379 | |
| Selina Bhattarai | 116 | 70 | 190 | 20 | 359 | |
| M. Babjuk | 88 | 75 | 263 | 19 | 374 | |
| Julia Seitz | 102 | 243 | 72 | 21 | 384 |
All Works
Login with ORCID to disown or claim papers
Loading papers...